-
Redefining political/medical/societal terminology: race vs ancestry, diversifying vs stratifying, “minority”, pharmacogenomics vs racialized medicine, pharmaco-economics and Health Equity
-
Assessing ancestral genomic research outcomes in reducing population-biased health disparities and moving toward Populations Health Equity
-
Investigating Biosensor, Nano-agents, HIgh-throughput Screening Models to study new target sequences and susceptibility genes ( e.g. TRPV6)
-
NIH and NSF Directors Special Pipeline Education and Training Session
-
Exploring approaches, such as the Ancestral Variant Theoretical Model and Equation, to address Precision Medicine and Precision Nutrition
